PSYREFLECT

Issue #38

May 14, 2026

#1Research

Idioms Lose Their Edge: ERP Markers of Schizotypy in Figurative Language

“When a patient cannot tell idiom from literal at the N400 stage, every metaphor we offer in session is a wager — confirm uptake before you build on it.”

schizotypyERPN400figurative language
3 minRead analysis →
#2Research

EEG microstates as a suicidality biomarker in OCD — a Beijing study points at the salience network

“OCD-related suicidality is a salience-network problem before it is a hopelessness problem — and it leaves a fingerprint on resting EEG that machine learning can read at 66% accuracy even within the disorder.”

OCDsuicidalityEEG microstatessalience network
3 minRead analysis →
#3Research

Ketamine's Real Address: Mu-Opioid Receptors on Somatostatin Interneurons — and a Map for the Next Generation of Antidepressants

“Ketamine's address in the brain is not "the NMDA receptor" — it is a mu-opioid receptor on a somatostatin interneuron in the medial prefrontal cortex, and that address is now drawn on the map.”

ketamine mechanismmu-opioid receptorsomatostatin interneuronsprefrontal cortex
3 minRead analysis →
#4Research

When the Proverb Lands Wrong: Figurative Language in Autism and Dyslexia

“Surface failure on figurative language looks the same in autism and dyslexia, but the mechanism differs — and so should the intervention target.”

metaphorfigurative-languageautismdyslexia
3 minRead analysis →
#5Research

HiTOP gets its self-report instrument: 11 factors, one community sample, the dimensional revolution edges closer

“A dimensional taxonomy with no instrument is a research argument; a dimensional taxonomy with a validated self-report is the start of a measurement infrastructure.”

HiTOPdimensional psychopathologypsychometricstransdiagnostic
3 minRead analysis →
#6Industry

At-Home tDCS Crosses the FDA Line: What Flow's FL-100 Approval Changes for the Practice

“Home neuromodulation is no longer experimental — but it is also not a stand-alone fix; the supervision burden has shifted to your office, just without the chair.”

neuromodulationtdcsdepressionfda-regulation
3 minRead analysis →